Saehoon Jung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saehoon Jung has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Andreas von Deimling
Department of Neuropathology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany
1 shared publication - Chang Hyun Nam
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea
1 shared publication Chanho Choi
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea
1 shared publication- Chungyeul Kim
Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
1 shared publication - Eui Hyun Kim
Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
1 shared publication - Hoon Kim
School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
1 shared publication
Latest Publications
- Top Cited Papers
- 8 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6781) , eadt0559
IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
Identifying the cell of origin that harbors an initial driver mutation is key to understanding tumor evolution and for the development of new treatments. For isocitrate dehydrogenase (IDH)–mutant gliomas, the most common malignant primary brain tumor in young adults, the cell of origin is currently poorly understood. We conducted deep sequencing on 142 tissues from 70 individuals comprising tumors, peritumoral cortex or subventricular zones, and blood. Low-level IDH mutations were found in the peritumoral cortex in 37.9% (11 of 29) of patients. Integrating cell-type–specific mutation analysis, the direction of clonal evolution, spatial transcriptomics from patient brains, and a cancer mouse model arising from mutant oligodendrocyte progenitor cell, we determined that glial progenitor cells harboring an initial IDH mutation were responsible for the development of IDH-mutant gliomas.
- 8 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6781) , eadt0559
Top Cited PapersIDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
Identifying the cell of origin that harbors an initial driver mutation is key to understanding tumor evolution and for the development of new treatments. For isocitrate dehydrogenase (IDH)–mutant gliomas, the most common malignant primary brain tumor in young adults, the cell of origin is currently poorly understood. We conducted deep sequencing on 142 tissues from 70 individuals comprising tumors, peritumoral cortex or subventricular zones, and blood. Low-level IDH mutations were found in the peritumoral cortex in 37.9% (11 of 29) of patients. Integrating cell-type–specific mutation analysis, the direction of clonal evolution, spatial transcriptomics from patient brains, and a cancer mouse model arising from mutant oligodendrocyte progenitor cell, we determined that glial progenitor cells harboring an initial IDH mutation were responsible for the development of IDH-mutant gliomas.